OMX Ventures
OMX Ventures is a venture capital firm that specializes in building scalable biotech companies using a technology-first approach. They focus on transformative technologies in the biotech sector, leveraging data from novel bio-tools, data, and artificial intelligence to create the next generation of medicines, tools, and solutions. Their mission is to support groundbreaking discoveries and grow them into scalable companies, particularly in the fields of therapeutics, bio-tools, diagnostics, and synthetic biology.
OMX Ventures
What We Do
OMX Ventures acts as a strategic partner deeply rooted in life sciences and intellectual property expertise, providing guidance on capital journey, company strategy, and future direction.
OMX Ventures offers hands-on support to help founders secure milestones, establish strong IP, and attract follow-on investor capital.
OMX Ventures leverages a seasoned network of advisors to help identify standout ideas and create a supportive ecosystem around founders.
Portfolio
Developing novel non-hallucinogenic versions of psychedelic compounds for psychiatric and neurological indications.
#Therapeutics
Revolutionizing women's health through restoration of healthy vaginal microbiomes, focusing on improving in-vitro fertilization efficacy.
#Therapeutics
Improving existing FDA-approved antibody therapies for oncology in terms of safety and efficacy.
#Therapeutics
Pioneering synthetic genomes and reprogramming genetic codes for sustainable materials and therapies.
#Synthetic Bio
Building a machine-learning software platform for faster mass spectrometry performance.
#BioTools & Diagnostics
Developing a CRISPR-based platform for near-instant molecular detection with high accuracy.
#BioTools & Diagnostics
Key People
Managing Director
Managing Director
Managing Director
Vice President
Vice President Investor Relations
Venture Partner